briakinumab

Psoriasis Drug Setback Highlights Abbott Pipeline Weaknesses
Seeking Alpha
Tue, 01/18/11 - 07:56 am
psoriasis
Abbott Laboratories
briakinumab
JNJ
Abbott Laboratories Withdrew U.S. BLA, MAA for Briakinumab
Bloomberg
Fri, 01/14/11 - 10:01 am
Abbott Laboratories
briakinumab
monoclonal antibodies
psoriasis